US 7704500
Methods of inhibiting ascites formation with modified chimeric VEGF polypeptides
granted A61KA61K38/00A61P
Quick answer
US patent 7704500 (Methods of inhibiting ascites formation with modified chimeric VEGF polypeptides) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/00, A61P, A61P43/00